west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "李宏" 6 results
  • Effects of DNA Methyltransferase Inhibitors and Histone Deacetylase Inhibitors on Expression of E-cadherin and Invasion of Cholangiocarcinoma Cell

    Objective To investigate the effects of DNA methyltransferase inhibitor (DNMTi) and histone deacetylase inhibitor (HDCAi) on expression of E-cadherin gene and invasiveness of cholangiocarcinoma cell. Methods According to different treatment, the QBC939 cells were divided into four groups: blank control group, hydralazine group, valproic acid group and hydralazine and valproic acid combined group. After 48 h, the expression of E-cadherin was evaluated by reverse transcription-PCR (RT-PCR), mehtylation specific PCR (MSP) and Western blot, the invasiveness of QBC939 cells was evaluated by Transwell method. Results There was no expression of E-cadherin mRNA and protien in blank control group and valproic acid group. The expressions of E-cadherin mRNA and protien in hydralazine and valproic acid combined group were higher than those in hydralazine group ( P < 0.01), while the invasiveness of QBC939 cells of hydralazine and valproic acid combined group was much lower than that of blank control group, hydralazine group and valproic acid group ( P < 0.01). Conclusion DNMTi and HDACi can synergistically re-express E-cadherin gene and weaken the invasiveness of QBC939 cell, which plays an important part in treatment of cholangiocarcinoma.

    Release date:2016-08-28 03:48 Export PDF Favorites Scan
  • Expression of Caspase-3 in Targeted Therapy with Magnetic Nanoparticle in Cholangiocarcinoma Xenograft of Nude Mice

    Objective To investigate the expression of caspase-3 in xenograft that was treated with targeted therapy with magnetic nanoparticles in nude mice. Methods QBC939 cell lines were injected into nude mice subcutaneously to establish the model of human cholangiocarcinoma xenograft. After two weeks of tumor inoculation, the animal models were divided randomly into 4 groups: group A received placebo (sodium chloride), group B were treated with magnetic nanoparticles (250 mg/kg), group C were treated with magnetic nanoparticles (150 mg /kg) combined with inner-stent, group D with magnetic nanoparticles (250 mg /kg) combined with inner-stent (the inner-stent was used to generate the magnetic targeting effect). The 21th day after treatment, expression of caspase-3 in tumor cells of each groups were measured with histochemical method and RT-PCR. Results The quantity of caspase-3 in tumor cells that were treated with magnetic nanoparticles (250 mg/kg) combined with inner-stent was the most (P<0.05), and the quantity of caspase-3 in cells of group C was significantly more than that of the other two groups (P<0.05). While the quantity of caspase-3 in group B was more than that of the control group(P<0.05). Conclusion The use of magnetic nanoparticles combined with inner-stent may increase the expression of caspase-3, and the expression is dose-dependent with magnetic nanoparticles.

    Release date: Export PDF Favorites Scan
  • Clinical Effect of Maintenance Therapy with Proton Pump Inhibitor in Reflux Esophagitis

    目的 研究质子泵抑制剂在反流性食管炎维持治疗的临床疗效。 方法 将2009年3月-月门诊及住院的121例反流性食管炎并胃镜证实病灶已愈合,且停药1周内症状又复发者,随机分为A、B、C 3组,3组均选用兰索拉唑。A组为兰索拉唑15 mg,1次/d,早餐前服;B组为兰索拉唑15 mg,1次/d,晚餐前服;C组兰索拉唑15 mg,2次/d,餐前服。3组疗程均为4周。疗程结束后进行临床症状疗效评定,并予复查胃镜,评价3组胃镜下总有效率,并观察3组不良反应。 结果 三种方案有效率分别为77.5%、95.0%、92.7%。 结论 晚餐前15 mg 1次/d的兰索拉唑为反流性食管炎较佳维持治疗方案。

    Release date:2016-09-08 09:47 Export PDF Favorites Scan
  • Diagnosis and endoscopic therapy of pancreaticobiliary maljunction: MDT discussion

    ObjectiveTo discuss the diagnosis and endoscopic therapy of pancreaticobiliary maljunction by multidisciplinary team (MDT).MethodThe preoperative MDT discussion and the diagnosis and treatment process of patient with pancreaticobiliary maljunction in the Fifth People’s Hospital of Zunyi in 2019 were summarized.ResultsThe patient was admitted for “upper abdominal pain approximately 10 h”. The obvious extramural confluence of the pancreaticobiliary tract was observed and the length of common channel was approximately 1.8 cm. But the junction of the pancreaticobiliary tract was obviously controlled by the sphincter of Oddi, and the amylase value of the bile was higher than that of the serum. After the MDT discussion, there were still doubts about the diagnosis of pancreaticobiliary maljunction or high confluence of pancreaticobiliary ducts. After the left hepatic lateral lobectomy and exploration of common bile duct, the amylase value of bile, which was collected by the T-tube, was still obviously increased. Then the endoscopic sphincterotomy was performed, the amylase value of the bile decreased obviously and no abnormality was found in the follow-up for half a year after discharge.ConclusionsConcept and diagnostic criteria of “Japanese clinical practice guidelines for pancreaticobiliary maljunction” are conflicting and inaccurate. Severity of pancreaticobiliary reflux and change of amylase value of bile might have a more important diagnostic value. Endoscopic sphincterotomy might be suitable for a few special types of pancreaticobiliary maljunction.

    Release date:2020-07-26 02:35 Export PDF Favorites Scan
  • The Application of Preservation of the Ring of Pylorus to the Reconstruction of the Digestive Tract by Interposition of Jejunum Following Total Gastrectomy

    目的总结腹腔镜胆囊切除术(LC)中预防胆管损伤的经验。方法回顾分析1995年10月至2002年9月LC2 694例临床资料。结果行LC 2 657例,其中加做肠瘘修补术; 1例坏疽性胆囊炎伴周围粘连致密者行胆囊造瘘术; 3例术中冰冻切片病理检查证实为胆囊癌,开腹行胆囊癌根治术; 1例术中发现胆囊癌晚期,仅行腹腔镜下活检术; 3例因术中出血,24例因炎症致密、胆管结构解剖不清或胆总管结石嵌顿中转开腹; 5例Mirizzi’s综合征Ⅱ型均中转开腹行瘘口修补、T管引流术。有5例因术后并发症行再次手术。无一例出现胆管损伤。结论为降低胆管损伤,术者应根据自身的器械设备、经验,合理掌握手术适应证。在处理炎症致密、胆管结构解剖不清时,可采用顺行、逆行分离结合。使用超声刀解剖,自制推结器结扎或可吸收施夹钳处理胆囊动脉、胆囊管,少用金属钛夹,减少电刀对胆管的直接或间接损伤。坚持以结扎胆囊动脉为先,尽量扩大胆囊三角。如胆管结构解剖不清、出血难止应及时中转开腹。

    Release date:2016-08-28 04:49 Export PDF Favorites Scan
  • EXPERIMENT OF ADIPOSE DERIVED STEM CELLS INDUCED INTO SMOOTH MUSCLE CELLS

    To study the feasibil ity of human adipose derived stem cells (ADSCs) in monolayer culture induced into smooth muscle cells in vitro as seeding cells in vascular tissue engineering. Methods The mononuclear cells in human adipose were separated by collagenase treatment and seeded on culture dishes with the density of 5 × 105/cm2. Cellswere cultured in M-199 plus 10% FBS. When reaching confluence, the cells were subcultured by 0.1% trypsin and 0.02%EDTA treatment, PDGF-BB (50 ng/mL) and TGF-β1 (5 ng/mL) were added at the passage 1 to enhance the smooth muscle cells’ phenotype. Cells were cultured under the inducing medium for 14 days. The morphology of induced cells was observed under the microscope. Cellular immunofluorescence and RT-PCR were used to determine the expression of smooth muscle cell markers of the post-induced cells. Flow cytometry (FACs) was used to examine the positive rate of induced team. Results Cocultured in M-199 media including TGF-β1 and PDGF-BB, the prol iferating capabil ity of the induced cells was significantly downregulated compared with the uninduced cells(P lt; 0.01). The induced cells exhibited “Hill and Valley” morphology, while the uninduced cells were similar to ADSCs of P0 which had the fibroblast-l ike morphology. The results of immunofluorescence indicated that the induced cells expressed smooth muscle (SM) cell- specific markers including α-smooth muscle actin (α-SMA), SM-myosin heavy chain (SM-MHC) and Calponin. The results of RT-PCR revealed that the induced cells also expressed α-SMA, SM-MHC, Calponin and SM-22α.The positive rates of α-SMA, SM-MHC and Calponin in FACs were 3.26% ± 1.31%, 3.55% ± 1.6% and 4.02% ± 1.81%, respectively, before the cells were induced. However, 14 days after the cell induction, the positive rates were 48.13% ± 8.31%, 45.33% ± 10.68% and 39.13% ± 9.42%, respectively. The positive rates in induced cells were remarkably higher than those in uninduced cells(P lt; 0.01). Conclusion The human ADSCs can be induced to express vascular smooth muscle markers, and they are a new potential source of vascular tissue engineering.

    Release date:2016-09-01 09:12 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content